NM_014855.3:c.281C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014855.3(AP5Z1):​c.281C>G​(p.Ser94Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0208 in 1,602,760 control chromosomes in the GnomAD database, including 454 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S94S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.016 ( 32 hom., cov: 33)
Exomes 𝑓: 0.021 ( 422 hom. )

Consequence

AP5Z1
NM_014855.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.12

Publications

7 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061022043).
BP6
Variant 7-4781669-C-G is Benign according to our data. Variant chr7-4781669-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128413.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.016 (2437/152362) while in subpopulation SAS AF = 0.0252 (122/4834). AF 95% confidence interval is 0.0226. There are 32 homozygotes in GnomAd4. There are 1153 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.281C>G p.Ser94Cys missense_variant Exon 3 of 17 ENST00000649063.2 NP_055670.1 O43299-1
AP5Z1NR_157345.1 linkn.374C>G non_coding_transcript_exon_variant Exon 3 of 17
AP5Z1NM_001364858.1 linkc.-103+357C>G intron_variant Intron 2 of 15 NP_001351787.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.281C>G p.Ser94Cys missense_variant Exon 3 of 17 NM_014855.3 ENSP00000497815.1 O43299-1

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2439
AN:
152246
Hom.:
32
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00427
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0179
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0252
Gnomad FIN
AF:
0.00640
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0236
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0173
AC:
4250
AN:
245016
AF XY:
0.0180
show subpopulations
Gnomad AFR exome
AF:
0.00382
Gnomad AMR exome
AF:
0.0138
Gnomad ASJ exome
AF:
0.0331
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00633
Gnomad NFE exome
AF:
0.0222
Gnomad OTH exome
AF:
0.0231
GnomAD4 exome
AF:
0.0213
AC:
30874
AN:
1450398
Hom.:
422
Cov.:
31
AF XY:
0.0216
AC XY:
15531
AN XY:
719112
show subpopulations
African (AFR)
AF:
0.00375
AC:
125
AN:
33302
American (AMR)
AF:
0.0150
AC:
669
AN:
44536
Ashkenazi Jewish (ASJ)
AF:
0.0324
AC:
844
AN:
26038
East Asian (EAS)
AF:
0.0000508
AC:
2
AN:
39354
South Asian (SAS)
AF:
0.0228
AC:
1960
AN:
86048
European-Finnish (FIN)
AF:
0.00677
AC:
353
AN:
52114
Middle Eastern (MID)
AF:
0.0488
AC:
280
AN:
5738
European-Non Finnish (NFE)
AF:
0.0229
AC:
25224
AN:
1103510
Other (OTH)
AF:
0.0237
AC:
1417
AN:
59758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1759
3518
5278
7037
8796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
962
1924
2886
3848
4810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0160
AC:
2437
AN:
152362
Hom.:
32
Cov.:
33
AF XY:
0.0155
AC XY:
1153
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00428
AC:
178
AN:
41578
American (AMR)
AF:
0.0178
AC:
273
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
111
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.0252
AC:
122
AN:
4834
European-Finnish (FIN)
AF:
0.00640
AC:
68
AN:
10628
Middle Eastern (MID)
AF:
0.0445
AC:
13
AN:
292
European-Non Finnish (NFE)
AF:
0.0235
AC:
1602
AN:
68040
Other (OTH)
AF:
0.0236
AC:
50
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
134
268
403
537
671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0211
Hom.:
23
Bravo
AF:
0.0172
TwinsUK
AF:
0.0240
AC:
89
ALSPAC
AF:
0.0200
AC:
77
ESP6500AA
AF:
0.00281
AC:
12
ESP6500EA
AF:
0.0245
AC:
208
ExAC
AF:
0.0171
AC:
2076
Asia WGS
AF:
0.00895
AC:
31
AN:
3478
EpiCase
AF:
0.0284
EpiControl
AF:
0.0272

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 20, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Hereditary spastic paraplegia 48 Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:2
Aug 30, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia Benign:1
Oct 09, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.030
T;T
Eigen
Benign
0.018
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.75
.;T
MetaRNN
Benign
0.0061
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.6
M;M
PhyloP100
3.1
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.5
N;.
REVEL
Benign
0.064
Sift
Benign
0.18
T;.
Sift4G
Benign
0.23
T;.
Polyphen
0.064
B;B
Vest4
0.19
ClinPred
0.015
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.077
gMVP
0.23
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11549839; hg19: chr7-4821300; API